Analyst Ratings for Rigel Pharmaceuticals (RIGL)
RIGL Rating Summary
RIGL Price Target Summary
- Highest: $1.75 (B.Riley)
- Lowest: $1.75 (B.Riley)
- Average: $1.75
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$1.75 (+54.9%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
Rating Score: 3.1 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/3/2023 | Piper Sandler | Allison Bratzel | New Coverage | Neutral (N/A) |
2.00 (N/A) |
1.34 (1.13) |
-15.67% | Details |
| 12/2/2022 | Citi | Yigal Nochomovitz | Upgrade | Buy (Neutral) |
2.00 (1.50) |
0.68 (1.13) |
66.18% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
